just his opinion,,,he probably does not cover the stock....there is very little research on this stock available at this time ...and there are no franking credits....hardly an analysis
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025